Daniel Lochner

CIK: 0001791187

Transaction Breakdown

Open Market Buys (P)2 (22.2%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (55.6%)

Compensation grants

Other (G, F, J, C, D, …)2 (22.2%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TECX

Tectonic Therapeutic, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

TECX
Tectonic Therapeutic, Inc.
Sep 25, 2026
Tax Payment(F)
Direct
520 shares at avg. $23.67$12K
TECX
Tectonic Therapeutic, Inc.
Sep 3, 2026
Award(A)
Employee Stock Option (Right to Buy)
Direct
24.3K shares-
TECX
Tectonic Therapeutic, Inc.
Jun 11, 2026
Award(A)
Performance Stock Option (Right to Buy)
Direct
7.5K shares-
TECX
Tectonic Therapeutic, Inc.
Mar 4, 2026
Award(A)
Direct
26.5K shares-
TECX
Tectonic Therapeutic, Inc.
Feb 10, 2026
Purchase(P)
Direct
6K shares at avg. $21.61$130K
TECX
Tectonic Therapeutic, Inc.
Feb 4, 2026
Tax Payment(F)
Direct
2.1K shares at avg. $23.22$48K
TECX
Tectonic Therapeutic, Inc.
Sep 25, 2025
Award(A)
Direct
5.4K shares-
TECX
Tectonic Therapeutic, Inc.
Feb 5, 2025
Purchase(P)
Direct
4.6K shares at avg. $54.14$250K
TECX
Tectonic Therapeutic, Inc.
Feb 4, 2025
Award(A)
Direct
18.1K shares-

		Type	Shares	Price		Ownership
Sep 25, 2026	TECX Tectonic Therapeutic, Inc.	Tax Payment(F)	520	$23.67	$12,308	Direct
Sep 3, 2026	TECX Tectonic Therapeutic, Inc.	Award(A) Employee Stock Option (Right to Buy)	24,250	-	-	Direct
Jun 11, 2026	TECX Tectonic Therapeutic, Inc.	Award(A) Performance Stock Option (Right to Buy)	7,500	-	-	Direct
Mar 4, 2026	TECX Tectonic Therapeutic, Inc.	Award(A)	26,500	-	$0	Direct
Feb 10, 2026	TECX Tectonic Therapeutic, Inc.	Purchase(P)	6,000	$21.61	$129,660	Direct
Feb 4, 2026	TECX Tectonic Therapeutic, Inc.	Tax Payment(F)	2,077	$23.22	$48,228	Direct
Sep 25, 2025	TECX Tectonic Therapeutic, Inc.	Award(A)	5,430	-	-	Direct
Feb 5, 2025	TECX Tectonic Therapeutic, Inc.	Purchase(P)	4,617	$54.14	$249,964	Direct
Feb 4, 2025	TECX Tectonic Therapeutic, Inc.	Award(A)	18,074	-	-	Direct

1-9 of 9 transactions

About Lochner Daniel

Lochner Daniel (SEC CIK 0001791187) files insider reports with the SEC as Chief Financial Officer of Tectonic Therapeutic, Inc. (TECX).

Signal8 holds 9 ownership filings by Lochner Daniel, all Form 4s, filed between Feb 6, 2025 and Oct 2, 2026. Those filings report 9 transactions, from Feb 4, 2025 to Sep 25, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lochner Daniel's filings is in WATERTOWN, MA.

Recent filings by Lochner Daniel

Sep 25, 2026: Tax withholding of TECX shares (Form 4, code F).
Sep 3, 2026: Grant or award of TECX derivative securities (Form 4, code A).
Jun 11, 2026: Grant or award of TECX derivative securities (Form 4, code A).
Mar 4, 2026: Grant or award of TECX shares (Form 4, code A).
Feb 10, 2026: Open-market purchase of TECX shares (Form 4, code P).

Other insiders filing for Tectonic Therapeutic, Inc. (TECX)

REICIN ALISE, Chief Executive Officer
McNamara Peter, Chief Scientific Officer
Ruddy Marcella K., Chief Medical Officer
Schwabish Marc, Chief Business Officer
SPRINGER TIMOTHY A, Director
Tipirneni Praveen P., Director

How to read Form 4 transaction codes